Lipocine Share Price

Lipocine Share Price

NASDAQ: LPCN | Micro Cap | Healthcare
$1.55
-$0.07 (-4.01%) Last updated on 19 Nov, 2026 | 00:45 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Lipocine Stock Performance

Open
$1.56
Prev. Close
$1.62
Circuit Range
N/A
Day Range
$1.56 - $1.56
Year Range
$1.38 - $12.35
Volume
568
Average Traded
$1.56

Lipocine Share Price Today

As of 19 November 2026, Lipocine Inc.'s share price is $1.55. The stock opened at $1.56, compared to its previous close of $1.62. During today's trading session, Lipocine Inc.'s share price traded between $1.56 and $1.56, with an average price of $1.56. Over the past 52 weeks, the stock has recorded a high of $12.35 and a low of $1.38. In terms of performance, Lipocine Inc.'s share price has declined by 31.50% over the last six months and is down 52.30% on a year-on-year basis.

Lipocine Share Price Chart

Line chart of the Lipocine price trend over the selected period. The price fell overall, ranging from 1.53 to 1.61, ending at 1.55.
$1.56$1.56
L
Show Current Price
H

Lipocine Stock Fundamentals & Key Indicators

Market Cap
$8.47M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.84
Revenue (TTM)
$1.98B
Return On Equity (TTM)
-44.09%
Profit Margin
-486.36%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
71.73%

Lipocine Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$1.15$0.00$0.00$2.10
Net Profit-$2.37-$3.67-$2.62-$0.67
Net Profit Margin-206.09%N/AN/A-31.90%
Income ChangeN/A-54.85%28.61%74.43%

Lipocine Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.50-$2.85$11.20$1.98
Net Profit-$10.76-$16.35$0.01-$9.63
Net Profit Margin-2152.00%573.68%0.09%-486.36%
Income ChangeN/A-51.95%100.06%-96400.00%

Lipocine Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets0.130.190.143.41
Current Assets16.8822.3222.8634.14
Total Assets17.0122.5123.037.54
Non Current Liabilities0.00.00.00.23
Current Liabilities2.531.512.631.68
Total Liabilities2.531.512.631.91
Shareholders' Equity14.4821.020.3735.63

Lipocine Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-9.76-1.22-11.87-11.97
Investing5.892.4513.0814.29
Financing2.870.210.4-2.13

Corporate Actions

Split
Ex-date: 12 May 2023

About Lipocine

Lipocine Inc is a clinical-stage biopharmaceutical company that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates, or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy (TRT). It also has other products in the pipeline, such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

Lipocine Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.41
$1.56
+9.44%
Oct 2026
$2.16
$1.43
-36.16%
Sep 2026
$2.36
$2.24
-0.44%
Aug 2026
$2.10
$2.25
+6.64%
Jul 2026
$2.46
$2.11
-18.53%
Jun 2026
$2.28
$2.59
+14.10%
May 2026
$2.38
$2.27
-3.40%
Apr 2026
$7.89
$2.35
-70.25%
Mar 2026
$9.35
$7.90
-20.68%
Feb 2026
$8.06
$9.96
+10.67%
Jan 2026
$8.02
$9.00
+10.02%
Dec 2025
$3.10
$8.18
+150.92%

Lipocine Share Price FAQs